.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Corticotropin - Generic Drug Details

« Back to Dashboard
Corticotropin is the generic ingredient in six branded drugs marketed by Sanofi Aventis Us, Parkedale, Organics Lagrange, Watson Labs, Mallinckrodt Ard, and Ani Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for corticotropin.

Summary for Generic Name: corticotropin

Tradenames:6
Patents:0
Applicants:6
NDAs:7
Drug Master File Entries: see list10
Formulation / Manufacturing:see details

Clinical Trials for: corticotropin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
ACTHAR
corticotropin
INJECTABLE;INJECTION007504-003Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Watson Labs
CORTICOTROPIN
corticotropin
INJECTABLE;INJECTION088772-001Nov 21, 1984DISCNNo<disabled><disabled>
Ani Pharms
PURIFIED CORTROPHIN GEL
corticotropin
INJECTABLE;INJECTION008975-002Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc